By David Bautz, PhD NASDAQ:XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Update on Chronic CN Program Chronic neutropenia (CN) is a disease that is defined as having severe, chronic (> 3 ...

By David Bautz, PhD NASDAQ:XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Case Studies of First Three Patients from Phase 2 CN Trial Presented at ASH 2023 On December 9, 2023, X4 ...